The DOI matches its Crossref record; 230 of the 230 references it cites were found in a registry or an index.
Cancer immunotherapy via dendritic cells
Open accessAbstract
Cancer immunotherapy attempts to harness the power and specificity of the immune system to treat tumours. The molecular identification of human cancer-specific antigens has allowed the development of antigen-specific immunotherapy. In one approach, autologous antigen-specific T cells are expanded ex vivo and then re-infused into patients. Another approach is through vaccination; that is, the provision of an antigen together with an adjuvant to elicit therapeutic T cells in vivo. Owing to their properties, dendritic cells (DCs) are often called 'nature's adjuvants' and thus have become the natural agents for antigen delivery. After four decades of research, it is now clear that DCs are at the centre of the immune system owing to their ability to control both immune tolerance and immunity. Thus, DCs are an essential target in efforts to generate therapeutic immunity against cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–230 of 230
Dendritic cells in cancer immunotherapy
Schuler, G. (2010) · European Journal of Immunology · doi:10.1002/eji.201040630 · Cited by 119
Paczesny, S., Banchereau, J., Wittkowski, K. M., Saracino, G., Fay, J. W., & Palucka, K. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20032118 · Cited by 117
Self-citationSystems vaccinology: learning to compute the behavior of vaccine induced immunity
Nakaya, H. I., Li, S., & Pulendran, B. (2011) · WIREs Systems Biology and Medicine · doi:10.1002/wsbm.163 · Cited by 114
Terabe, M., Ambrosino, E., Takaku, S., O’Konek, J. J., Venzon, D. J., Lonning, S. M., McPherson, J. M., & Berzofsky, J. A. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-1066 · Cited by 112
The role of dendritic cell precursors in tumour vasculogenesis
Coukos, G., Benencia, F., Buckanovich, R. J., & Conejo-Garcia, J. R. (2005) · British Journal of Cancer · doi:10.1038/sj.bjc.6602476 · Cited by 112
Differences in Tumor Regulatory T-Cell Localization and Activation Status Impact Patient Outcome
Ménétrier‐Caux, C., Gobert, M., & Caux, C. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-1642 · Cited by 111
Plasmacytoid dendritic cells regulate B-cell growth and differentiation via CD70
Shaw, J. L., Wang, Y., Ito, T., Arima, K., & Liu, Y.-J. (2010) · Blood · doi:10.1182/blood-2009-08-239145 · Cited by 110
Regulatory T Cells Selectively Control CD8+ T Cell Effector Pool Size via IL-2 Restriction
Kastenmüller, W., Gasteiger, G., Subramanian, N., Sparwasser, T. D., Busch, D. H., Belkaid, Y., Drexler, I., & Germain, R. N. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1101649 · Cited by 109
Neuroimmunology of the paraneoplastic neurological degenerations
Roberts, W. K., & Darnell, R. B. (2004) · Current Opinion in Immunology · doi:10.1016/j.coi.2004.07.009 · Cited by 108
Dunne, A., Marshall, N. A., & Mills, K. H. G. (2011) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2011.03.004 · Cited by 98
(2000) · PubMed · Cited by 94
Defining dendritic cells by conditional and constitutive cell ablation
Bar‐On, L., & Jung, S. (2010) · Immunological Reviews · doi:10.1111/j.0105-2896.2009.00875.x · Cited by 92
How to improve the immunogenicity of chemotherapy and radiotherapy
Ma, Y., Conforti, R., Aymeric, L., Locher, C., Kepp, O., Kroemer, G., & Zitvogel, L. (2011) · Cancer and Metastasis Reviews · doi:10.1007/s10555-011-9283-2 · Cited by 91
Schuster, S. J., Neelapu, S. S., Gause, B. L., Muggia, F. M., Gockerman, J. P., Sotomayor, E. M., Winter, J. N., Flowers, C. R., Stergiou, A. M., & Kwak, L. W. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2009.27.15_suppl.2 · Cited by 85
Schwartzentruber, D. J., Lawson, D. J., Richards, J. M., Conry, R. M., Miller, D. M., Triesman, J., Gailani, F., Riley, L., Vena, D. A., & Hwu, P. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2009.27.15_suppl.cra9011 · Cited by 83
Romano, E., Rossi, M., Ratzinger, G., de Cos, M.-A., Chung, D. J., Panageas, K. S., Wolchock, J. D., Houghton, A. N., Chapman, P. B., Heller, G., et al. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-3421 · Cited by 82
Ni, L., Gayet, I., Zurawski, S., Duluc, D., Flamar, A.-L., Li, X., O’Bar, A., Clayton, S., Palucka, A. K., Zurawski, G., et al. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.1000999 · Cited by 81
Self-citationAarntzen, E. H. J. G., Srinivas, M., de Wilt, J. H. W., Jacobs, J. F. M., Lesterhuis, W. J., Windhorst, A. D., Troost, E. G. C., Bonenkamp, J. J., van Rossum, M. M., Blokx, W. A. M., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1113045108 · Cited by 79
Regulation of dendritic cell differentiation and function by Notch and Wnt pathways
Cheng, P., Zhou, J. H. S., & Gabrilovich, D. I. (2010) · Immunological Reviews · doi:10.1111/j.0105-2896.2009.00871.x · Cited by 63
Clinical Development of Listeria monocytogenes–Based Immunotherapies
Le, D. T., Dubensky, T. W., & Brockstedt, D. G. (2012) · Seminars in Oncology · doi:10.1053/j.seminoncol.2012.02.008 · Cited by 63
Zapata-Gonzalez, F., Rueda, F., Pétriz, J., Domingo, P., Villarroya, F., de Madariaga, M. A., & Domingo, J. C. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.10.6130 · Cited by 57
Romano, E., Cotari, J. W., da Silva, R. B., Betts, B. C., Chung, D. J., Avogadri, F., Fink, M. J., Angelo, E. T. S., Mehrara, B. J., Heller, G., et al. (2012) · Blood · doi:10.1182/blood-2011-09-382200 · Cited by 54
Dendritic Cells: Are They Clinically Relevant?
Palucka, K., Ueno, H., Roberts, L. K., Fay, J. W., & Banchereau, J. (2010) · The Cancer Journal · doi:10.1097/ppo.0b013e3181eaca83 · Cited by 54
Self-citationDakappagari, N., Maruyama, T., Renshaw, M. W., Tacken, P., Figdor, C., Torensma, R., Wild, M. A., Wu, D., Bowdish, K., & Kretz-Rommel, A. (2006) · Journal of Immunology · doi:10.4049/jimmunol.176.1.426 · Cited by 52
van der Aar, A. M. G., de Groot, R., Sánchez‐Hernández, M., Taanman-Kueter, E. W., van Lier, R. A. W., Teunissen, M. B. M., de Jong, E. C., & Kapsenberg, M. L. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1101105 · Cited by 49
Banchereau, J., Zurawski, S., Thompson-Snipes, L., Blanck, J.-P., Clayton, S., Munk, A., Cao, Y., Wang, Z., Khandelwal, S., Hu, J., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1205785109 · Cited by 47
Self-citationFlacher, V., Sparber, F., Tripp, C. H., Romani, N., & Stoitzner, P. (2008) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-008-0563-9 · Cited by 47
Paradigm Shifts in Cancer Vaccine Therapy
Schlom, J., Gulley, J. L., & Arlen, P. M. (2008) · Experimental Biology and Medicine · doi:10.3181/0708-mr-226 · Cited by 46
Antibody responses initiated by Clec9A-bearing dendritic cells in normal and Batf3−/− mice
Caminschi, I., Vremec, D., Ahmet, F., Lahoud, M. H., Villadangos, J. A., MURPHY, K. M. M., Heath, W. R., & Shortman, K. (2011) · Molecular Immunology · doi:10.1016/j.molimm.2011.11.008 · Cited by 46
Dendritic cells in cancer immunotherapy: vaccines or autologous transplants?
Kaliński, P., Edington, H. D. J., Zeh, H. J., Okada, H., Butterfield, L. H., Kirkwood, J. M., & Bartlett, D. L. (2011) · Immunologic Research · doi:10.1007/s12026-011-8224-z · Cited by 32
Cited by
Microenvironmental regulation of tumor progression and metastasis
Quail, D. F., & Joyce, J. A. (2013) · Nature Medicine · doi:10.1038/nm.3394 · Cited by 7,994
Immune evasion in cancer: mechanistic basis and therapeutic strategies
Vinay, D. S., Ryan, E. P., Pawelec, G., Talib, W. H., Stagg, J., Elkord, E., Lichtor, T., Decker, W. K., Whelan, R. L., Kumara, H. M. C. S., et al. (2015) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2015.03.004 · Cited by 1,625
Fever and the thermal regulation of immunity: the immune system feels the heat
Evans, S. S., Repasky, E. A., & Fisher, D. T. (2015) · Nature Reviews Immunology · doi:10.1038/nri3843 · Cited by 1,257
Towards personalized, tumour-specific, therapeutic vaccines for cancer
Hu, Z., Ott, P. A., & Wu, C. J. (2018) · Nature Reviews Immunology · doi:10.1038/nri.2017.131 · Cited by 1,067
Dai, Y., Xu, C., Sun, X., & Chen, X. (2017) · Chemical Society Reviews · doi:10.1039/c6cs00592f · Cited by 931
Metadata
- Authors
- Palucka, K., & Banchereau, J.
- Venue
- Nature Reviews Cancer
- Published
- 2012-03-22
- Volume
- 12
- Issue
- 4
- Pages
- 265-277
- ISSN
- 1474-175X (ISSN-L)
- 1474-1768
- OpenAlex
- W2050216284
- Cited by
- 2,049
- References
- 230
- FWCI
- 8.25
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.